NCT07431359Recruiting
Evaluation of Dietary Knowledge and the Habit of Using the Mediterranean Diet in Patients With Diabetes
RELATIONSHIP Between ALimentary Knowledge and Adherence to the Mediterranean Diet in Patients With DIABete Mellito Type 2 Attending an Outpatient Service (REALDIAB)
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
The main aim of this study is to evaluate nutritional knowledge and adherence to the Mediterranean diet through the administration of questionnaires in patients with type 2 Diabetes Mellitus belonging to Outpatient Diabetology Service of the Hospital.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 10 Feb 2026
- Start date
- 22 May 2025
- Primary completion date
- 19 May 2026
- Lead sponsor
- Casa di Cura Dott. Pederzoli
- Diseases
- Type 2 diabetes
- NCT number
- NCT07431359
What you commit to
- Study type: Observational
- Planned participants: 500
- From 22 May 2025 to the primary completion date, 19 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with Diabetes Mellitus type 1
Other
- Patients with insulin T2DM treated
Who the study is looking for
- T2DM in nutritional and/or pharmacological euglycemic treatment (metformin, gliptins, gliflozines, incretin mimetics, pioglitazone)
- Signing of informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ospedale P. Pederzoli Casa di Cura Privata S.p.A. Coordinator of this site? Confirm its status | Peschiera del Garda | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.